Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02335294 · ClinicalTrials.gov registry record · Phase 2
A Study of TRV130 for the Treatment of Pain After Abdominoplasty
A Phase 2 study, sponsored by Trevena.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT02335294 is a Phase 2 study that has completed, run by Trevena. The registered enrollment target is 200 participants.
The verdict
NCT02335294, a Phase 2 study, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.
Interventions
- DRUG Placebo
- DRUG Morphine
- DRUG TRV130
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02335294
The ClinicalTrials.gov registry entry for NCT02335294 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02335294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02335294 about?
NCT02335294 is a clinical study titled "A Study of TRV130 for the Treatment of Pain After Abdominoplasty". The primary objective is to evaluate the analgesic efficacy of IV TRV130 compared with placebo in patients with acute postoperative pain following abdominoplasty.
What is the current status of trial NCT02335294?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2014-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02335294?
The interventions under investigation include: Placebo (DRUG), Morphine (DRUG), TRV130 (DRUG).
Who is sponsoring clinical trial NCT02335294?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.